Effect of abatacept on the immunogenicity of 23-valent pneumococcal polysaccharide vaccination (PPSV23) in rheumatoid arthritis patients

Overview of attention for article published in Arthritis Research & Therapy, December 2015

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (89th percentile)
Good Attention Score compared to outputs of the same age and source (76th percentile)

Mentioned by

news: 2 news outlets

Citations

dimensions_citation: 52 Dimensions

Readers on

mendeley: 65 Mendeley

Summary News Dimensions citations

So far, Altmetric has seen 2 news stories from 2 outlets.

Orencia Does Not Ruin Pneumonia Vax Efficacy

MedPage Today, 18 Dec 2015

Action Points Rheumatoid arthritis (RA) patients taking abatacept (Orencia) produce less IgG in response to the 23-valent…

Effect of abatacept on the immunogenicity of 23-valent pneumococcal polysaccharide vaccination (PPSV23) in rheumatoid arthritis patients

Bioportfolio, 10 Dec 2015

IntroductionPatients with rheumatoid arthritis (RA) treated with abatacept (ABT) are at increased risk for vaccine-preventable…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.